Skip to main content
. 2021 Jan 28;8:628029. doi: 10.3389/fmed.2021.628029

Table 3.

Summary of endocrine dysfunctions and mechanisms in critical illness and ME/CFS.

Name of Axis Dysfunctions
Prolonged critical illness and ME/CFS
Mechanisms
Prolonged critical illness
HPA Axis Prolonged critical illness:
- Lower than expected cortisol levels
- Loss of pulsatile ACTH release
ME/CFS:
- Lower cortisol baseline
- Blunted HPA axis response to stressors
- Increased negative feedback
- Loss of morning ACTH peak
Hypothalamus: cytokine-mediated increase in abundance and affinity of glucocorticoids receptors (GRs) inhibits CRH release
Pituitary: increase in abundance of GRs inhibits ACTH release
Adrenal gland: adrenal atrophy (due to lack of pulsatile ACTH stimulation during acute phase)
HPS Axis Prolonged critical illness:
- Loss of pulsatile GH release
- Low or normal IGF-1
ME/CFS:
- Low nocturnal GH
- Mixed response to stimulation
- Failed response to exercise (fibromyalgia)
- Low or normal IGF-1
Hypothalamus: lack of stimulation by ghrelin; change in relative amounts of hypothalamic stimulating/inhibiting hormones (GHRH/GHIH) dampens GH release
Pituitary: lack of stimulation by ghrelin dampens GH release
HPT Axis Prolonged critical illness
- Loss of pulsatile TSH release
- Lower T3
- (Lower T4)
- Higher rT3:T3
ME/CFS:
- (Lower Free T3)
- Higher rT3:T3
Hypothalamus: cytokine-induced alteration in set-point for release of TRH (local upregulation of T4 to T3 conversion)
Pituitary: cytokine-mediated suppression of TSH secretion
Thyroid gland: cytokine-mediated reduction in T4 secretion by the thyroid gland.
Periphery: upregulation of T3 to rT3 conversion (notably in liver), tissue specific alteration in T3 uptake (i.e., reception and transport), etc.